IC
NVAX icon

IEQ Capital’s Novavax NVAX Stock Holding History

IEQ Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$955K Buy
+101,355
New +$908K ﹤0.01% 1114

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

IEQ Capital's NVAX Position: Q2 2026 in Review

IEQ Capital opened a new position in Novavax (NVAX) in Q2 2026: 101,355 shares worth $955K. The stake represents ﹤0.01% of the portfolio and ranks #1114 among its holdings.

266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • IEQ Capital held 101,355 shares of Novavax worth $955K as of Q2 2026.
  • Novavax was a new IEQ Capital position in Q2 2026.
  • Novavax made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1114 holding.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.